Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • Peer reviewer login
  • Alerts
  • Subscriptions

TAPSE associated to RV/LV index in patients with moderate-high risk pulmonary embolism

Ana Gomez Larrauri, Jose Luis Lobo, Angel Alonso, Naiara Parraza, Raquel Morillo, Deisy Barrios, Rosa Nieto, David Jimenez
European Respiratory Journal 2016 48: PA2454; DOI: 10.1183/13993003.congress-2016.PA2454
Ana Gomez Larrauri
1Pneumonology, Araba University Hospital, Vitoria-Gasteiz, ArabaSpain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jose Luis Lobo
1Pneumonology, Araba University Hospital, Vitoria-Gasteiz, ArabaSpain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Angel Alonso
2Cardiology, Araba University Hospital, Vitoria-Gasteiz, ArabaSpain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Naiara Parraza
3Research Unit, Araba University Hospital, Vitoria-Gasteiz, ArabaSpain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raquel Morillo
4Pneumonology, Ramon y Cajal Hospital, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Deisy Barrios
4Pneumonology, Ramon y Cajal Hospital, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rosa Nieto
4Pneumonology, Ramon y Cajal Hospital, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Jimenez
4Pneumonology, Ramon y Cajal Hospital, Madrid, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

INTRODUCTION: Guidelines of PE recommend that intermediate risk patients should be classified in low and high-intermediate.Patients selected according to current recommendations present no more than 15%complications at 30days when traditional echocardiographic criteria were used.Our Group recently demonstrated that TAPSE added to RV/LV improves prognostic efficacy of classical parameters(p<0.001).

OBJECTIVE: Evaluate RV/LV>1 +TAPSE<16mm instead of traditional criteria to determine capacity to select intermediate-high risk patients.

METHODS: 848 patients diagnosed with stable PE.Severity was evaluated using sPESI.Classical criteria of RVD was determined with 2:dilatation RV,hypokinesis RVorPAP>30mmHg.The criteria we propose includes RV/LV>1+TAPSE<16mm.Complicated clinical course(CCC)considered when death, sustained hypotension,cardiopulmonary arrest,endotracheal intubation or vasoactive support occured.Students t-test,Mann-Whitney Utest and Fisher's test were used.Level of significance set at p<0.05.

RESULTS: 7.4%patients presented CCC.63.1%were classified as intermediate risk(sPESI>0)and 18.3%also had(+)Troponin.Positive predictive value(PPV)for CCC of combination sPESI>0,(+)Troponin and RVD with classical criteria was 18.4%whereas PPV using the proposed criteria was 29.6%.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

CONCLUSION: In PE patients with intermediate risk the presence of RVD with the proposed new criteria can identify more efficiently patients with higher risk of CCC.

  • Embolism
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
TAPSE associated to RV/LV index in patients with moderate-high risk pulmonary embolism
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
TAPSE associated to RV/LV index in patients with moderate-high risk pulmonary embolism
Ana Gomez Larrauri, Jose Luis Lobo, Angel Alonso, Naiara Parraza, Raquel Morillo, Deisy Barrios, Rosa Nieto, David Jimenez
European Respiratory Journal Sep 2016, 48 (suppl 60) PA2454; DOI: 10.1183/13993003.congress-2016.PA2454

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
TAPSE associated to RV/LV index in patients with moderate-high risk pulmonary embolism
Ana Gomez Larrauri, Jose Luis Lobo, Angel Alonso, Naiara Parraza, Raquel Morillo, Deisy Barrios, Rosa Nieto, David Jimenez
European Respiratory Journal Sep 2016, 48 (suppl 60) PA2454; DOI: 10.1183/13993003.congress-2016.PA2454
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Figures & Data
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Neutrophils' atomic force microscopy in COPD with pulmonary hypertension (PH)
  • Hemodynamic and anti-remodelling effect of the Rho kinase inhibitor Y-27632 in the monocrotaline pulmonary arterial hypertension rat model
  • Targeting aquaporin 1 reverses hypoxia-induced pulmonary hypertension in mice
Show more 4.3 Pulmonary Circulation and Pulmonary Vascular Diseases

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society